Abstract

Summary

This paper investigates how light exposure during darkness disrupts circadian photoreception through intrinsically photosensitive retinal ganglion cells (ipRGCs), which are most sensitive to ~480 nm (blue) light, potentially suppressing melatonin and promoting tumor growth. For healthcare and lighting designers, this underscores the importance of minimizing blue-wavelength light exposure during nighttime hours, particularly in hospital and home environments for cancer patients.
Abstract

Key Findings

  • ipRGCs in rats and monkeys show peak spectral sensitivity around 480 nm, even when synaptic input from rods and cones is blocked, confirming their autonomous photosensitivity.
  • Nocturnal light exposure, particularly at short (blue) wavelengths, is implicated in circadian disruption and may promote tumor biology through melatonin suppression pathways.
Categories

Categories

Sleep & Circadian Health: Paper examines how light exposure during darkness disrupts circadian photoreception via ipRGCs, with direct implications for melatonin suppression and cancer risk.
The Science of Light: Focuses on ipRGC spectral sensitivity (~480 nm peak) and photoreceptor biology underlying circadian disruption by nocturnal light exposure.
Patient Recovery: Explores relationships between light-at-night-induced circadian disruption and tumor biology, with implications for cancer treatment and patient outcomes.
Authors

Author(s)

SA Jasser, DE Blask, GC Brainard
Publication Date

Publication Year

2006
Citations

Number of Citations

105
View more publications